SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-14-008431
Filing Date
2014-05-14
Accepted
2014-05-14 18:27:37
Documents
1
Period of Report
2014-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2895
  Complete submission text file 0001179110-14-008431.txt   4627
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Reporting) CIK: 0001080014 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36033 | Film No.: 14843061
SIC: 2834 Pharmaceutical Preparations

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations